ArticleJournal of comparative effectiveness research2024
Why is target trial emulation not being used in health technology assessment real-world data submissions?
Article in Journal of comparative effectiveness research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- From study design to executable code: automating target trial emulation with large language models.JAMIA open · 2026Article
- R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 24.Journal of comparative effectiveness research · 2026Article
- R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 21.Journal of comparative effectiveness research · 2025Article
- FRAME: Framework for Real-World Evidence Assessment to Mitigate Evidence Uncertainties for Efficacy/Effectiveness - An Evaluation of Regulatory and Health Technology Assessment Decision Making.Clinical pharmacology and therapeutics · 2025Article
- Strengthening health technology assessment for cancer treatments in Europe by integrating causal inference and target trial emulation.The Lancet regional health. Europe · 2025Review
- R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 18.Journal of comparative effectiveness research · 2025Article
- How life-cycle real-world evidence can bridge evidentiary gaps in precision oncology.Frontiers in medicine · 2025Article
- R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 17.Journal of comparative effectiveness research · 2025Article
- RWE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 16.Journal of comparative effectiveness research · 2024Article
Corrections and comments
- Comment on
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.